July 1999
Volume 40, Issue 8
Free
Retinal Cell Biology  |   July 1999
The Rhodopsin Content of Human Eyes
Author Affiliations
  • Anne B. Fulton
    The Department of Ophthalmology, Children’s Hospital and Harvard Medical School, Boston, Massachusetts; and
  • Janice Dodge
    The Biomedical Research Facility, Department of Biology, The Florida State University, Tallahassee, Florida.
  • Ronald M. Hansen
    The Department of Ophthalmology, Children’s Hospital and Harvard Medical School, Boston, Massachusetts; and
  • Theodore P. Williams
    The Biomedical Research Facility, Department of Biology, The Florida State University, Tallahassee, Florida.
Investigative Ophthalmology & Visual Science July 1999, Vol.40, 1878-1883. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anne B. Fulton, Janice Dodge, Ronald M. Hansen, Theodore P. Williams; The Rhodopsin Content of Human Eyes. Invest. Ophthalmol. Vis. Sci. 1999;40(8):1878-1883.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

purpose. To measure the total amount of rhodopsin in human eyes across the life span and to test the hypothesis that the rhodopsin content of infants’ and the elderly’s eyes is lower than at other ages.

methods. Rhodopsin was extracted from retinal and pigment epithelial fractions of 196 eyes of 102 donors, ages 27 weeks’ gestation through 94 years, using quantitative procedures. To recover photopigment bleached by unavoidable light exposure, the fractions from 78 eyes were incubated with 9-cis retinal. The total photopigment (retinal plus pigment epithelial fractions) per eye was examined for significant changes with age, using the higher value from pairs of eyes.

results. The median rhodopsin content of the higher eye of adults is 6.45 nmoles (range, 3.33–10.84 nmoles) with 8 nmoles or more recovered from 28% of all adult eyes. The rhodopsin content of infants’ eyes (<12 months postterm) is significantly lower than that of older individuals and increases with age. After infancy, no change with age is found. For both infants and adults, 9-cis retinal significantly increases the amount of photopigment recovered without reducing the variance in the amount of photopigment recovered. The rhodopsin content is estimated to be 50% of the median adult amount early in infancy, approximately 5 weeks postterm (95% confidence interval, 0–10 weeks postterm).

conclusions. A developmental increase in rhodopsin content occurs during infancy. Thereafter rhodopsin content remains constant. The amount of rhodopsin recovered from human eyes is quite variable. Bleaching alone cannot explain the variability.

Development of the human rod outer segments (ROS) begins at preterm ages and continues with further elongation of the ROS after term. 1 As in other species, it has been suspected that developmental elongation of human ROS, which proceeds after the addition of rod cells has ceased, is accompanied by an increase in rhodopsin content and scotopic retinal sensitivity. Previous measurements 2 3 have indicated that the amount of rhodopsin in infants’ eyes is lower than in adults’, implying a developmental increase in rhodopsin content. However, a sufficient number of measurements have not been available to define the developmental course. After infancy, scotopic sensitivity remains constant 4 5 6 until after the age of 60 years when slight deficits in scotopic sensitivity are found. 7 8 It has been reasoned that the deficits in scotopic sensitivity at either end of the age span may be due to receptoral or postreceptoral factors, or a combination of the two. 4 5 7 9 10  
Thus, it is of interest to define the course of age-related changes in the rhodopsin content of the human eye. Since our previous reports, 2 3 we have more than tripled the sample size and added a 9-cis retinal regeneration procedure to evaluate the effect of possible bleaching on rhodopsin content. The rhodopsin content of the eyes, ranging in age from the preterm weeks to more than 90 years, has been examined for significant changes with age. 
Methods
Eyes (n = 196) from 102 donors, 27 weeks’ gestation through 94 years of age, were obtained through eye banks, or in the case of the preterm infants, at autopsy. Data from 30 of these donors have been reported before. 3 All globes appeared normal, and no donor had a history of eye problems except uncomplicated cataract surgery in three elderly donors. 
As previously described, 2 3 each globe was placed in a petri dish, containing 5 ml 0.9% saline, and bisected in an anteroposterior plane. The entire retina was teased free, placed in 5 ml distilled water, and vigorously stirred with a stainless steel spatula; this was designated the retinal fraction. The pigment epithelium and choroid were teased from the scleral shell, placed in a separate tube along with the saline from the petri dish and stirred vigorously; this was designated the pigment epithelial (PE) fraction. Each of these fractions was processed separately. The samples were centrifuged at 12,000g for 10 minutes at 4oC and the supernatant discarded. 
Extraction of the photopigment was done with 1% CTAB (cetyl trimethyl-ammonium bromide; Sigma, St. Louis, MO), 2 3 or 1% Emulphogene (Sigma) in 50 mM Tris-acetate buffer, pH 6.9. The results obtained with CTAB and Emulphogene are considered together in this report because the mean rhodopsin recovered from 20 pairs of adults’ eyes [CTAB (mean = 8.19, SD = 1.63 nmoles); Emulphogene (mean = 6.67, SD = 1.99 nmoles)] did not differ significantly, and the median λmax was 496 nm for both. 
Before extraction with detergent, the retinal and PE fractions of 78 eyes were incubated with the synthetic chromophore 9-cis retinal to regenerate photopigment that had been bleached by uncontrolled light exposure during procurement of the globes. The individual retinal and PE fractions were incubated in the dark with an excess (3–4 μl) of 9-cis retinal (final concentration, 10 nmoles/ml) for 1 hour at 20oC and then centrifuged at 12,000g for 15 minutes. The supernatant was discarded, and 5 ml of detergent solution was added to each pellet. The pellets were disrupted with a spatula and incubated in the dark for 1 hour at 20oC, and spun again at 12,000g for 10 minutes. The 78 eyes included 37 for which the fellow eye was not incubated with 9-cis retinal, and only native rhodopsin (with 11-cis retinal) was assayed. 
After the final spin, an aliquot of the supernatant was removed and scanned 820 to 190 nm using an HP-8452A diode array spectrophotometer to obtain the absorbance spectrum. Then the extract was exposed to white light for 6 minutes and scanned again. For each specimen, the absorbance of photopigment at itsλ max was obtained by the difference spectrum. The number of nanomoles of photopigment present in each retinal and PE fraction was calculated using the Beer–Lambert equation and summed to obtain an estimate of the total amount of photopigment in each eye. Extinction coefficients of 42,000 M−1 · cm−1 for rhodopsin and 43,000 M−1 · cm−1 for isorhodopsin 11 were used. To determine whether isorhodopsin was present in the 9-cis retinal–supplemented samples, the method of wavelength shift 12 13 14 was used. This technique makes use of the fact that isorhodopsin absorbs at shorter wavelengths (λmax = 486 nm) than does rhodopsin, and mixtures of the two photopigments produce a composite spectrum with a λmax between those of the native rhodopsin and the artificially produced isorhodopsin. 
The effect of age on the amount of photopigment recovered per eye was analyzed. Because light exposure and incomplete recovery of rhodopsin bearing tissues were possible explanations for recovery of spuriously low amounts of photopigment, but because artifactually high values were unlikely to result from the procedures described above, the higher amount of photopigment obtained from a pair of eyes was used for analysis of the effect of age. If only one eye was available (n = 8 donors), that eye was used in the analysis. A logistic growth curve 3 15 16 of the form  
\[\mathit{y}\mathrm{/}\mathit{y}_{\mathit{max}}\mathrm{{=}}\mathit{age}^{\mathrm{n}}\mathrm{/(}\mathit{age}^{\mathrm{n}}\mathrm{{+}}\mathit{C}^{\mathrm{n}}\mathrm{)}\]
where C is the age at which y is 50% of the adult value y max, provides a good summary of the course of rhodopsin increase during development in other species and was to be considered as a descriptor of human rhodopsin development. 
Results
The amounts of photopigment recovered from the 196 eyes are summarized in Table 1 . The data from eyes having only native rhodopsin (opsin + 11-cis retinal) studied, and those having fractions incubated with 9-cis retinal, are listed separately. For all 108 adult eyes, 28% had 8 nmoles or more of native rhodopsin recovered. For all groups (Table 1) , the amounts of photopigment recovered from eyes treated with 9-cis retinal overlap broadly and are analyzed further below. 
For native rhodopsin, λmax did not vary with age. The median value was 496 nm, and 90% of the values are within 2 nm of this value. Similar values (496–498 nm) have been reported previously for extracted human rhodopsin. 17 18 19 20 As the spectra in Figure 1 illustrate, the difference spectrum obtained from a 9-cis retinal–supplemented sample may be shifted to shorter wavelengths, indicating the presence of a mixture of isorhodopsin and rhodopsin rather than rhodopsin alone. The median λmax for the 9-cis retinal–supplemented samples was 492 nm (range, 486–500 nm). 
The distribution of λmax values obtained from 9-cis retinal–supplemented and nonsupplemented eyes of the 37 paired samples is compared in Figure 2 . For the supplemented samples, there was a significant shift of the distribution to shorter wavelengths (t = −5.43; df = 36; P < 0.01). Among individual pairs (n = 37), supplementation achieved a large increment in photopigment in some, whereas there was no increase in others (range of differences between 9-cis retinal–supplemented and nonsupplemented samples: +5.96 nmoles higher to −0.41 nmoles lower). The increment in amount of photopigment recovered was significantly correlated with that of nanometers thatλ max was shifted, from 496 nm to shorter wavelengths (r = 0.41; P < 0.02). The increment for 9-cis retinal treatment is similar in infant and older donors. For the infants (n = 9), the amount recovered from the nonsupplemented eye (mean = 3.23; SD = 2.46 nmoles) was 66% of that recovered from the supplemented eye (mean = 4.87; SD = 2.57 nmoles). For the older donors (2–94 years; n = 28), the amount recovered from the nonsupplemented eye (mean = 4.42; SD = 2.26 nmoles) was 70% of that recovered from the supplemented eye (mean = 6.28; SD = 2.08 nmoles). Despite achieving the expected increment in photopigment by 9-cis retinal supplementation, the variability in the amount of photopigment recovered was not significantly reduced. There was no significant difference in the variance of the supplemented and nonsupplemented samples (F = 1.18; df = 36,36; NS). 
The normalized, photopigment content of the 102 donors is shown as a function of age in Figure 3 . For donors contributing pairs of eyes, the result from the eye with the higher amount of photopigment is shown. Only during infancy is there a significant change in the amount photopigment recovered (y = 2.178 × −45; r 2 = 0.38; t = 3.39; P = 0.003). In no other age group is there a significant change with age. The amount of photopigment recovered from young adults (21–39 years; n = 17) and older adults (>64 years; n = 25) does not differ significantly. Specifically, for the higher eye of young adults, median rhodopsin content was 4.95 (4.09–10.84) nmoles, and median photopigment for supplemented samples was 6.55 (4.51–8.50) nmoles; and of older adults, median rhodopsin content was 6.78 (3.33–10.84) nmoles, and median photopigment in supplemented samples was 7.13 (3.55–10.1) nmoles. According to the growth curve shown in Figure 3 , the age at which rhodopsin content of the eye is 50% of that in adults is 5 weeks (95% confidence interval, 0–10 weeks postterm). 
Discussion
These data show that the rhodopsin content of infants’ eyes is lower than in adults and that the rhodopsin content increases significantly during infancy, when a developmental increase in visual sensitivity occurs. 5 9 Thus, a lower amount of rhodopsin, and consequent lower probability of photon capture by rhodopsin in the outer segments, cannot be disregarded as one of the fundamental determinants of infants’ lower scotopic visual sensitivity. At the other end of the life span, although loss of photoreceptors and quantum catching capability were considered as possibly contributing to an average deficit of 0.5 log unit in scotopic visual sensitivity 7 and 0.2 log unit deficit in scotopic b-wave sensitivity 4 in older observers, postreceptoral factors appeared more likely. The rhodopsin data of the present study are consistent with this conclusion. 
The amounts of pigment recovered are quite variable at all ages (Table 1 ; Fig. 3 ). Some of the variability is likely due to bleaching of rhodopsin around the time that the eyes were procured. This supposition is consistent with the higher amount of photopigment found in eyes treated with 9-cis retinal. However, even among the 9-cis retinal–supplemented samples from adults, the standard deviation for nanomoles of photopigment recovered is approximately 33% of the mean, a little lower than that for the nonsupplemented samples for which the standard deviation is nearly 50% of the mean. However, even 33% is higher than the standard deviation typically obtained in laboratory experiments using the same type of extraction and regeneration procedures as used herein. 14 21 Possibly, the regeneration achieved with the 9-cis retinal procedure in human retinas is less complete than in laboratory experiments, although control experiments did not indicate this to be the case. Thus, in human eyes, the variation in rhodopsin content may be controlled not only by the acute light history but also by other factors. For example, from retina to retina there is some variation in the number of rods present. Curcio and coworkers 22 report that the number of rods in the human retina ranges from 77.9 to 107.3 million. In other words, the number of rods in some retinas may be more than 25% lower than that in eyes with the largest number of rods. With aging, a 30% loss of rod cells in central retina is reported. 23 24 25 Thus, cell loss may contribute to the variability of rhodopsin content in the older adult group; however, given the standard deviations of approximately 50% of the mean values, the effect of loss of central rods may not produce a detectable change in rhodopsin content. Another factor that could affect the amount of rhodopsin in the human retina is long-term light history. In infants and adults of other species, a bright habitat induces short outer segments and a low rhodopsin content; a long-term adaptation to dim habitats induces long outer segments and a high rhodopsin content. 26 27 28  
Despite the variability that appears in these quantitative assays of rhodopsin, the difference between the rhodopsin content in infants and adults is significant. Surely this must accompany the development of ROS structure and function. 
 
Table 1.
 
Table 1.
 
Amount of Photopigment Recovered Per Eye
Table 1.
 
Table 1.
 
Amount of Photopigment Recovered Per Eye
Age (years) Higher Eye Fellow Eye
Native Rhodopsin (nmoles) 9-cis Retinal Supplemented (nmoles) Native Rhodopsin (nmoles) 9-cis Retinal Supplemented (nmoles)
Infants 2.00 6.47 1.80 6.40, 6.88
(27 wk gest. to 11 mo) (0.14–3.79) (1.70–10.26) (0.08–6.27)
(24 donors, 44 eyes) n = 13* n = 11* n = 18 n = 2
Children 3 6.82 6.88 4.70 7.43
(1–13 years) (2.10–7.98) (1.45–8.81) (1.31–6.78)
(13 donors, 25 eyes) n = 5 n = 8 n = 11 n = 1
Adolescents 19 5.27 6.50 5.13
(13–21 years) (1.72–8.99) (4.01–9.81) (0.14–7.24)
(10 donors, 19 eyes) n = 5 n = 5 n = 9 None
Adults 59 6.45 7.19 4.63 6.91
(21–94 years) (3.33–10.84) (2.33–10.50) (2.55–9.22) (2.55–9.70)
(55 donors, 108 eyes) n = 23 n = 32 n = 34 n = 19
Figure 1.
 
Sample spectra for native rhodopsin (solid line) and rhodopsin plus isorhodopsin (9-cis retinal–supplemented sample; dashed line). These are from a 49-year-old donor. Rhodopsin, 8.34 nmoles withλ max = 496 nm, was recovered from one eye, and 10.24 nmoles photopigment, with λmax = 493 nm, was recovered from the fellow eye that had been supplemented with 9-cis retinal.
Figure 1.
 
Sample spectra for native rhodopsin (solid line) and rhodopsin plus isorhodopsin (9-cis retinal–supplemented sample; dashed line). These are from a 49-year-old donor. Rhodopsin, 8.34 nmoles withλ max = 496 nm, was recovered from one eye, and 10.24 nmoles photopigment, with λmax = 493 nm, was recovered from the fellow eye that had been supplemented with 9-cis retinal.
Figure 2.
 
Distribution of λmax values. These data are from the 37 pairs of eyes, one of which was supplemented with 9-cis retinal (open bars) and the fellow eye had only native rhodopsin extracted (black bars). The distribution for the 9-cis–supplemented samples is shifted to shorter wavelengths (median, λmax 492 nm), suggesting a mixture of rhodopsin, and isorhodopsin is represented in some of these supplemented samples. The median λmax for the rhodopsin values is 496nm.
Figure 2.
 
Distribution of λmax values. These data are from the 37 pairs of eyes, one of which was supplemented with 9-cis retinal (open bars) and the fellow eye had only native rhodopsin extracted (black bars). The distribution for the 9-cis–supplemented samples is shifted to shorter wavelengths (median, λmax 492 nm), suggesting a mixture of rhodopsin, and isorhodopsin is represented in some of these supplemented samples. The median λmax for the rhodopsin values is 496nm.
Figure 3.
 
The normalized amount of photopigment as a function of age. The points (•) represent the result from the higher eye (Table 1) of each of the 102 donors. If the higher eye had native rhodopsin assayed, the value was normalized to the median adult value of 6.45 nmoles (Table 1) . If the higher eye had been supplemented with 9-cis retinal, the value was normalized to the median adult value of 7.19 nmoles (Table 1) . For those donors having only one eye studied, the amount of photopigment was normalized to the appropriate adult median for native rhodopsin, or 9-cis retinal–supplemented samples (Table 1) . Adults are shown in 3 columns: young (21–40 years; n = 17), middle-aged (40–65 years; n = 13), and older (≥65 years; n = 25). As indicated, donors were not evenly distributed throughout infancy. Therefore, clusters of infantile data are represented by median age and median percentage of photopigment (□) as follows: preterms (ages 27–35 weeks’ gestation, n = 5); around term, 40 to 42 weeks’ gestation (n = 8); and median age, 4 months postterm (3–11 months; n = 11). The median percentages of photopigment in children, adolescents, and adults are also shown (□); the median ages are in Table 1 . The smooth line is a logistic growth curve fit to the medians (□). The equation for this curve is y/year max = age n/(age n + C n), where y max = 100%, n = 7.2, and C = 5 weeks, the age at which rhodopsin is 50% of the adult value.
Figure 3.
 
The normalized amount of photopigment as a function of age. The points (•) represent the result from the higher eye (Table 1) of each of the 102 donors. If the higher eye had native rhodopsin assayed, the value was normalized to the median adult value of 6.45 nmoles (Table 1) . If the higher eye had been supplemented with 9-cis retinal, the value was normalized to the median adult value of 7.19 nmoles (Table 1) . For those donors having only one eye studied, the amount of photopigment was normalized to the appropriate adult median for native rhodopsin, or 9-cis retinal–supplemented samples (Table 1) . Adults are shown in 3 columns: young (21–40 years; n = 17), middle-aged (40–65 years; n = 13), and older (≥65 years; n = 25). As indicated, donors were not evenly distributed throughout infancy. Therefore, clusters of infantile data are represented by median age and median percentage of photopigment (□) as follows: preterms (ages 27–35 weeks’ gestation, n = 5); around term, 40 to 42 weeks’ gestation (n = 8); and median age, 4 months postterm (3–11 months; n = 11). The median percentages of photopigment in children, adolescents, and adults are also shown (□); the median ages are in Table 1 . The smooth line is a logistic growth curve fit to the medians (□). The equation for this curve is y/year max = age n/(age n + C n), where y max = 100%, n = 7.2, and C = 5 weeks, the age at which rhodopsin is 50% of the adult value.
Hendrickson AE. The morphologic development of human and monkey retina. Albert DM Jakobiec FA eds. Principles and Practice of Ophthalmology: Basic Sciences. 1994;561–577. WB Saunders Philadelphia.
Fulton AB, Dodge J, Schremser J. –L, et al. The quantity of rhodopsin in human eyes. Curr Eye Res.. 1990;9:1211–1216. [CrossRef]
Fulton AB, Dodge J, Hansen RM, Schremser J. –L, Williams TP. The quantity of rhodopsin in young human eyes. Curr Eye Res.. 1991;10:977–982.
Birch DG, Anderson JL. Standardized full-field electroretinography: normal values and their variation with age. Arch Ophthalmol. 1992;110:1571–1576. [CrossRef] [PubMed]
Hansen RM, Fulton AB. Development of scotopic retinal sensitivity. Simons K eds. Early Visual Development, Normal and Abnormal. 1993;130–142. Oxford University Press New York.
Pulos E. Changes in rod sensitivity through adulthood. Invest Ophthalmol Vis Sci. 1989;30:1738–1742. [PubMed]
Jackson GR, Owsley C, Price–Cordle E, Finley CD. Aging and scotopic sensitivity. Vision Res. 1998;38:3655–3662. [CrossRef] [PubMed]
Sturr JF, Zang L, Taub HA, Hannon DJ, Jackowski MM. Psychophysical evidence for losses in rod sensitivity in the aging visual system. Vision Res. 1997;37:475–481. [CrossRef] [PubMed]
Brown AM. Development of visual sensitivity to light and color in human infants: a critical review. Vision Res. 1990;30:1159–1188. [CrossRef] [PubMed]
Hood DC. Testing hypotheses about development with electroretinographic and increment threshold data. J Opt Soc Am A. 1988;5:2159–2165. [PubMed]
Eder DJ, Williams TP. A method of isorhodopsin analysis and the photoreversal of rhodopsin intermediates. Am J Optom Arch Am Acad Optom. 1973;50:765–776. [CrossRef] [PubMed]
Bridges CDB. Studies on the flash photolysis of visual pigments, I: pigments present in frog-rhodopsin solutions after flash-irradiation. Biochem J. 1961a;79:128–134.
Bridges CDB. Studies on the flash photolysis of visual pigments, II: production of thermally stable photosensitive pigments in flash-irradiated solutions of frog rhodopsin. Biochem J. 1961b;79:135–143.
Dodge J, Fulton AB, Parker C, Hansen RM, Williams TP. Rhodopsin in immature rod outer segments. Invest Ophthalmol Vis Sci. 1996;37:1951–1956. [PubMed]
Fulton AB, Hansen RM, Findl O. The development of the rod photoresponse from dark adapted rats. Invest Ophthalmol Vis Sci. 1995;36:1038–1045. [PubMed]
Hoglund G, Nilsson SE, Schwemer J. Visual pigment and visual receptor cells in adult sheep. Invest Ophthalmol Vis Sci. 1982;23:409–418. [PubMed]
Crescitelli F, Dartnall HJA. Human visual purple. Nature. 1953;172:195–197. [CrossRef] [PubMed]
Crescitelli F. Some properties of solubilized human rhodopsin. Exp Eye Res. 1985;40:521–535. [CrossRef] [PubMed]
van Kuijk FGM, Lewis JW, Buck P, Parker KR, Kliger DS. Spectrophotometric quantitation of rhodopsin in the human retina. Invest Ophthalmol Vis Sci. 1991;32:1962–1967. [PubMed]
Wald G, Brown PK. Human rhodopsin. Science. 1958;127:222–226. [CrossRef] [PubMed]
Fulton AB, Reynaud X, Hansen RM, et al. Rod photoreceptors in infant rats with a history of oxygen exposure. Invest Ophthalmol Vis Sci. 1999;40:168–174. [PubMed]
Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497–523. [CrossRef] [PubMed]
Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993;34:3278–3296. [PubMed]
Curcio CA, Drucker DA. Retinal ganglion cells in Alzheimer’s disease and aging. Ann Neurol. 1993;33:248–257. [PubMed]
Gao H, Hollyfield JG. Aging of the human retina: differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1992;33:1–17. [PubMed]
Penn JS, Williams TP. Photostasis: regulation of daily photon-catch by rat retinas in response to various cyclic illuminances. Exp Eye Res. 1986;43:915–928. [CrossRef] [PubMed]
Pugh EN, Jr, Falsini B, Lyubarsky AL. The origin of the major rod and cone driven components of the rodent electroretinogram and the effect of age and light rearing history on the magnitude of these components. Williams TP Thistle AB eds. Photostasis and Related Phenomena. 1998;93–128. Plenum Press New York.
Fulton A, Hansen R, Dodge J, William T. Photoreceptor development and photostasis. Williams TP Thistle A eds. Photostasis and Related Phenomena. 1998;189–198. Plenum Press New York.
Figure 1.
 
Sample spectra for native rhodopsin (solid line) and rhodopsin plus isorhodopsin (9-cis retinal–supplemented sample; dashed line). These are from a 49-year-old donor. Rhodopsin, 8.34 nmoles withλ max = 496 nm, was recovered from one eye, and 10.24 nmoles photopigment, with λmax = 493 nm, was recovered from the fellow eye that had been supplemented with 9-cis retinal.
Figure 1.
 
Sample spectra for native rhodopsin (solid line) and rhodopsin plus isorhodopsin (9-cis retinal–supplemented sample; dashed line). These are from a 49-year-old donor. Rhodopsin, 8.34 nmoles withλ max = 496 nm, was recovered from one eye, and 10.24 nmoles photopigment, with λmax = 493 nm, was recovered from the fellow eye that had been supplemented with 9-cis retinal.
Figure 2.
 
Distribution of λmax values. These data are from the 37 pairs of eyes, one of which was supplemented with 9-cis retinal (open bars) and the fellow eye had only native rhodopsin extracted (black bars). The distribution for the 9-cis–supplemented samples is shifted to shorter wavelengths (median, λmax 492 nm), suggesting a mixture of rhodopsin, and isorhodopsin is represented in some of these supplemented samples. The median λmax for the rhodopsin values is 496nm.
Figure 2.
 
Distribution of λmax values. These data are from the 37 pairs of eyes, one of which was supplemented with 9-cis retinal (open bars) and the fellow eye had only native rhodopsin extracted (black bars). The distribution for the 9-cis–supplemented samples is shifted to shorter wavelengths (median, λmax 492 nm), suggesting a mixture of rhodopsin, and isorhodopsin is represented in some of these supplemented samples. The median λmax for the rhodopsin values is 496nm.
Figure 3.
 
The normalized amount of photopigment as a function of age. The points (•) represent the result from the higher eye (Table 1) of each of the 102 donors. If the higher eye had native rhodopsin assayed, the value was normalized to the median adult value of 6.45 nmoles (Table 1) . If the higher eye had been supplemented with 9-cis retinal, the value was normalized to the median adult value of 7.19 nmoles (Table 1) . For those donors having only one eye studied, the amount of photopigment was normalized to the appropriate adult median for native rhodopsin, or 9-cis retinal–supplemented samples (Table 1) . Adults are shown in 3 columns: young (21–40 years; n = 17), middle-aged (40–65 years; n = 13), and older (≥65 years; n = 25). As indicated, donors were not evenly distributed throughout infancy. Therefore, clusters of infantile data are represented by median age and median percentage of photopigment (□) as follows: preterms (ages 27–35 weeks’ gestation, n = 5); around term, 40 to 42 weeks’ gestation (n = 8); and median age, 4 months postterm (3–11 months; n = 11). The median percentages of photopigment in children, adolescents, and adults are also shown (□); the median ages are in Table 1 . The smooth line is a logistic growth curve fit to the medians (□). The equation for this curve is y/year max = age n/(age n + C n), where y max = 100%, n = 7.2, and C = 5 weeks, the age at which rhodopsin is 50% of the adult value.
Figure 3.
 
The normalized amount of photopigment as a function of age. The points (•) represent the result from the higher eye (Table 1) of each of the 102 donors. If the higher eye had native rhodopsin assayed, the value was normalized to the median adult value of 6.45 nmoles (Table 1) . If the higher eye had been supplemented with 9-cis retinal, the value was normalized to the median adult value of 7.19 nmoles (Table 1) . For those donors having only one eye studied, the amount of photopigment was normalized to the appropriate adult median for native rhodopsin, or 9-cis retinal–supplemented samples (Table 1) . Adults are shown in 3 columns: young (21–40 years; n = 17), middle-aged (40–65 years; n = 13), and older (≥65 years; n = 25). As indicated, donors were not evenly distributed throughout infancy. Therefore, clusters of infantile data are represented by median age and median percentage of photopigment (□) as follows: preterms (ages 27–35 weeks’ gestation, n = 5); around term, 40 to 42 weeks’ gestation (n = 8); and median age, 4 months postterm (3–11 months; n = 11). The median percentages of photopigment in children, adolescents, and adults are also shown (□); the median ages are in Table 1 . The smooth line is a logistic growth curve fit to the medians (□). The equation for this curve is y/year max = age n/(age n + C n), where y max = 100%, n = 7.2, and C = 5 weeks, the age at which rhodopsin is 50% of the adult value.
Table 1.
 
Table 1.
 
Amount of Photopigment Recovered Per Eye
Table 1.
 
Table 1.
 
Amount of Photopigment Recovered Per Eye
Age (years) Higher Eye Fellow Eye
Native Rhodopsin (nmoles) 9-cis Retinal Supplemented (nmoles) Native Rhodopsin (nmoles) 9-cis Retinal Supplemented (nmoles)
Infants 2.00 6.47 1.80 6.40, 6.88
(27 wk gest. to 11 mo) (0.14–3.79) (1.70–10.26) (0.08–6.27)
(24 donors, 44 eyes) n = 13* n = 11* n = 18 n = 2
Children 3 6.82 6.88 4.70 7.43
(1–13 years) (2.10–7.98) (1.45–8.81) (1.31–6.78)
(13 donors, 25 eyes) n = 5 n = 8 n = 11 n = 1
Adolescents 19 5.27 6.50 5.13
(13–21 years) (1.72–8.99) (4.01–9.81) (0.14–7.24)
(10 donors, 19 eyes) n = 5 n = 5 n = 9 None
Adults 59 6.45 7.19 4.63 6.91
(21–94 years) (3.33–10.84) (2.33–10.50) (2.55–9.22) (2.55–9.70)
(55 donors, 108 eyes) n = 23 n = 32 n = 34 n = 19
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×